Apr 8 |
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
|
Mar 22 |
Savara Announces New Employment Inducement Grant
|
Mar 7 |
Savara GAAP EPS of -$0.09 beats by $0.01
|
Mar 7 |
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
|
Mar 6 |
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
|
Feb 20 |
Savara Inc. (NASDAQ:SVRA): Are Analysts Optimistic?
|
Feb 15 |
JMP starts Savara at buy, cites market potential for lung disease drug
|
Jan 31 |
Savara to Present at Two Upcoming Healthcare Conferences
|
Jan 2 |
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
|
Dec 30 |
Insider Sell: CEO Matthew Pauls Disposes of 84,000 Shares of Savara Inc (SVRA)
|